Jubilant Ingrevia Ltd's Q3FY25 Quarter Results
- 29 Jan 2025
Result Summary
- Jubilant Ingrevia Ltd reported a 1.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 9.3%.
- Its expenses for the quarter were down by 0.5% QoQ and up 5.5% YoY.
- The net profit increased 17.6% QoQ and increased 79.9% YoY.
- The earnings per share (EPS) of Jubilant Ingrevia Ltd stood at 4.4 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 1066.20 | 1055.70 | 975.18 | 1.0% | 9.3% |
Total Expenses | 970.63 | 975.34 | 920.13 | -0.5% | 5.5% |
Profit Before Tax | 95.57 | 80.22 | 55.05 | 19.1% | 73.6% |
Tax | 26.20 | 21.22 | 16.52 | 23.5% | 58.6% |
Profit After Tax | 69.38 | 59.00 | 38.56 | 17.6% | 79.9% |
Earnings Per Share | 4.40 | 3.70 | 2.40 | 18.9% | 83.3% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Jubilant Ingrevia Ltd is a prominent company engaged in the production and distribution of specialty chemicals, nutritional products, and life science chemicals. As part of the Jubilant Bhartia Group, it operates within the broad chemical industry, catering to a diverse range of sectors including pharmaceuticals, agrochemicals, and personal care. Recently, the company has been focusing on expanding its product portfolio and increasing its production capacity to meet rising demand. However, specific recent developments regarding strategic initiatives or partnerships were not available in the provided data.
Revenue
Jubilant Ingrevia Ltd reported a total income of ₹1066.20 crores for Q3FY25, reflecting a quarter-over-quarter increase of 1.0% from ₹1055.70 crores in Q2FY25, and a year-over-year growth of 9.3% from ₹975.18 crores in Q3FY24. This upward trend in revenue over both periods indicates sustained growth in the company's income streams. The consistent increase suggests that the company's revenue strategies may be effectively driving growth, supported by an expanding product line and possibly increased market penetration.
Profitability
The company's profitability metrics have shown significant improvements. Profit Before Tax (PBT) for Q3FY25 was ₹95.57 crores, marking an increase of 19.1% compared to Q2FY25's ₹80.22 crores, and a substantial 73.6% rise from ₹55.05 crores in Q3FY24. The Profit After Tax (PAT) also rose to ₹69.38 crores in Q3FY25, reflecting a 17.6% increase from the previous quarter and an impressive 79.9% year-over-year growth from ₹38.56 crores. Earnings Per Share (EPS) increased to ₹4.40 in Q3FY25, compared to ₹3.70 in Q2FY25 and ₹2.40 in Q3FY24. This growth trajectory in both PAT and EPS highlights the company's enhanced profitability, potentially driven by effective cost management and operational efficiencies.
Operating Metrics
In terms of operating metrics, Jubilant Ingrevia Ltd's total expenses for Q3FY25 amounted to ₹970.63 crores, a slight decrease of 0.5% from Q2FY25's ₹975.34 crores. Year-over-year, expenses increased by 5.5% from ₹920.13 crores in Q3FY24. The relatively stable expense figures, alongside growing income, suggest a favorable operating environment. Tax expenses increased by 23.5% QoQ to ₹26.20 crores and by 58.6% YoY from ₹16.52 crores, which aligns with the increased profitability. These financial metrics indicate an effective management of operating costs, contributing to the overall financial health of the company.
